Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW), 11979-11980 [2019-06092]

Download as PDF Federal Register / Vol. 84, No. 61 / Friday, March 29, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Healthcare Infection Control Practices Advisory Committee (HICPAC) ACTION: Notice. The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the HICPAC. The HICPAC consists of 14 experts in fields including but not limited to, infectious diseases, infection prevention, healthcare epidemiology, nursing, clinical microbiology, surgery, hospitalist medicine, internal medicine, epidemiology, health policy, health services research, public health, and related medical fields. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of infectious diseases, infection prevention, healthcare epidemiology, nursing, environmental and clinical microbiology, surgery, internal medicine, and public health. Federal employees will not be considered for membership. Members may be invited to serve for four-year terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of HICPAC objectives https://www.cdc.gov/hicpac/. DATES: Nominations for membership on the HICPAC must be received no later than August 2, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027, emailed (recommended) to hicpac@ cdc.gov, or faxed to (404)639–4043. FOR FURTHER INFORMATION CONTACT: KooWhang Chung, MPH, HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027; hicpac@cdc.gov. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, jbell on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:48 Mar 28, 2019 Jkt 247001 gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees (SGEs), requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for HICPAC membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July 2020, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06090 Filed 3–28–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 11979 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women (ACBCYW) ACTION: Notice. The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the ACBCYW. The ACBCYW consists of 15 experts in fields associated with breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women, or in related disciplines with a specific focus on young women. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of breast health, breast cancer, disease prevention and risk reduction, survivorship (including metastatic breast cancer), hereditary breast and ovarian cancer (HBOC), or in related disciplines with a specific focus on young women. Persons with personal experience with early onset breast cancer are also eligible to apply. This includes, but may not be limited to breast cancer survivors <45 years of age and caregivers of said persons. Federal employees will not be considered for membership. Members may be invited to serve up to four-year terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of ACBCYW objectives (https://www.cdc.gov/maso/ facm/facmacbcyw.html). DATES: Nominations for membership on the ACBCYW must be received no later than July 8, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Temeika L. Fairley, Ph.D. c/o ACBCYW Secretariat, Centers for Disease Control and Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia 30341, or emailed (recommended) to acbcyw@cdc.gov. FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D. Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway SUMMARY: E:\FR\FM\29MRN1.SGM 29MRN1 jbell on DSK30RV082PROD with NOTICES 11980 Federal Register / Vol. 84, No. 61 / Friday, March 29, 2019 / Notices NE, Mailstop F–76, Atlanta, Georgia 30341; 770–488–4518; acbcyw@cdc.gov. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for ACBCYW membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in November 2020, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address). D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 17:48 Mar 28, 2019 Jkt 247001 Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06092 Filed 3–28–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3375–N] Announcement of the Approval of the Accreditation Association for Hospitals and Health Systems/ Healthcare Facilities Accreditation Program (Formerly Known as the American Osteopathic Association/ Healthcare Facilities Accreditation Program) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This notice announces the approval of the application of the Accreditation Association for Hospitals and Health Systems/Healthcare Facilities Accreditation Program (AAHHS/HFAP) as an accreditation organization for clinical laboratories under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) program for all specialty and subspecialty areas under CLIA. We have determined that the AAHHS/HFAP meets or exceeds the applicable CLIA requirements. We are announcing the approval and granting the AAHHS/ HFAP deeming authority for a period of 4 years. DATES: The approval announced in this notice is effective from March 29, 2019 to March 29, 2023. FOR FURTHER INFORMATION CONTACT: Kathleen Todd, (410)786–3385. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background and Legislative Authority On October 31, 1988, the Congress enacted the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (Pub. L. 100–578), which amended section 353 of the Public Health Service Act. We implemented the accreditation provisions of CLIA in the final rule published in the July 31, 1992 Federal Register (57 FR 33992). Under those provisions, we may grant PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 deeming authority to an accreditation organization if its requirements for laboratories accredited under its program are equal to or more stringent than the applicable CLIA program requirements in 42 CFR part 493 (Laboratory Requirements). Subpart E of part 493 (Accreditation by a Private, Nonprofit Accreditation Organization or Exemption under an Approved State Laboratory Program) specifies the requirements an accreditation organization must meet to be approved by CMS as an accreditation organization under CLIA. II. Notice of Approval of the AAHHS/ HFAP as an Accreditation Organization In this notice, we approve and grant deeming authority to the Accreditation Association for Hospitals and Health Systems/Healthcare Facilities Accreditation Program (AAHHS/HFAP) as an organization that may accredit laboratories for purposes of establishing their compliance with CLIA requirements for all specialty and subspecialty areas under CLIA. We have examined the initial AAHHS/HFAP application and all subsequent submissions to determine its accreditation program’s equivalency with the requirements for approval of an accreditation organization under subpart E of part 493. We have determined that AAHHS/HFAP meets or exceeds the applicable CLIA requirements. We have also determined that AAHHS/HFAP will ensure that its accredited laboratories will meet or exceed the applicable requirements in subparts H, I, J, K, M, Q, and the applicable sections of R. Therefore, we grant AAHHS/HFAP approval as an accreditation organization under subpart E of part 493, for the period stated in the DATES section of this notice for all specialty and subspecialty areas under CLIA. As a result of this determination, any laboratory that is accredited by AAHHS/ HFAP during the time period stated in the DATES section of this notice will be deemed to meet the CLIA requirements for the listed subspecialties and specialties, and therefore, will generally not be subject to routine inspections by a state survey agency to determine its compliance with CLIA requirements. However, the accredited laboratory may be subject to validation and complaint inspection surveys performed by CMS, or its agent(s). E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 84, Number 61 (Friday, March 29, 2019)]
[Notices]
[Pages 11979-11980]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06092]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Breast Cancer in Young Women (ACBCYW)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the ACBCYW. The ACBCYW consists 
of 15 experts in fields associated with breast cancer, disease 
prevention, early detection, diagnosis, public health, social 
marketing, genetic screening and counseling, treatment, rehabilitation, 
palliative care, and survivorship in young women, or in related 
disciplines with a specific focus on young women. Nominations are being 
sought for individuals who have expertise and qualifications necessary 
to contribute to the accomplishments of the committee's objectives. 
Nominees will be selected based on expertise in the fields of breast 
health, breast cancer, disease prevention and risk reduction, 
survivorship (including metastatic breast cancer), hereditary breast 
and ovarian cancer (HBOC), or in related disciplines with a specific 
focus on young women. Persons with personal experience with early onset 
breast cancer are also eligible to apply. This includes, but may not be 
limited to breast cancer survivors <45 years of age and caregivers of 
said persons. Federal employees will not be considered for membership. 
Members may be invited to serve up to four-year terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of ACBCYW objectives (https://www.cdc.gov/maso/facm/facmacbcyw.html).

DATES: Nominations for membership on the ACBCYW must be received no 
later than July 8, 2019. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to Temeika L. Fairley, 
Ph.D. c/o ACBCYW Secretariat, Centers for Disease Control and 
Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia 
30341, or emailed (recommended) to [email protected].

FOR FURTHER INFORMATION CONTACT: Temeika L. Fairley, Ph.D. Designated 
Federal Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway

[[Page 11980]]

NE, Mailstop F-76, Atlanta, Georgia 30341; 770-488-4518; 
[email protected].

SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human 
Services policy stipulates that committee membership be balanced in 
terms of points of view represented, and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens, and cannot be full-time employees of 
the U.S. Government. Current participation on federal workgroups or 
prior experience serving on a federal advisory committee does not 
disqualify a candidate; however, HHS policy is to avoid excessive 
individual service on advisory committees and multiple committee 
memberships. Committee members are Special Government Employees, 
requiring the filing of financial disclosure reports at the beginning 
and annually during their terms. CDC reviews potential candidates for 
ACBCYW membership each year, and provides a slate of nominees for 
consideration to the Secretary of HHS for final selection. HHS notifies 
selected candidates of their appointment near the start of the term in 
November 2020, or as soon as the HHS selection process is completed. 
Note that the need for different expertise varies from year to year and 
a candidate who is not selected in one year may be reconsidered in a 
subsequent year.
    Nominees must be U.S. citizens, and cannot be full-time employees 
of the U.S. Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06092 Filed 3-28-19; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.